Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19.
Messina V, Nevola R, Izzi A, De Lucia Sposito P, Marrone A, Rega R, Fusco R, Lumino P, Rinaldi L, Gaglione P, Simeone F, Sasso FC, Maggi P, Adinolfi LE.
Messina V, et al. Among authors: adinolfi le.
Sci Rep. 2022 Apr 6;12(1):5771. doi: 10.1038/s41598-022-09741-5.
Sci Rep. 2022.
PMID: 35388092
Free PMC article.